{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:59:10Z","timestamp":1792051150157,"version":"4.4.0"},"reference-count":18,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T00:00:00Z","timestamp":1601164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T00:00:00Z","timestamp":1601164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1111\/dth.14261","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T16:16:38Z","timestamp":1599063398000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Apremilast in dermatology: A review of literature"],"prefix":"10.1155","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4780-7074","authenticated-orcid":false,"given":"David","family":"Nassim","sequence":"first","affiliation":[{"name":"Faculty of Medicine McGill University  Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alajmi","sequence":"additional","affiliation":[{"name":"Division of Dermatology McGill University, Jewish General Hospital  Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhadi","family":"Jfri","sequence":"additional","affiliation":[{"name":"Division of Dermatology McGill University, Jewish General Hospital  Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2950-4603","authenticated-orcid":false,"given":"Kevin","family":"Pehr","sequence":"additional","affiliation":[{"name":"Division of Dermatology McGill University, Jewish General Hospital  Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,9,27]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00559.x"},{"key":"e_1_2_7_3_1","unstructured":"Celgene Corporation. Otezla (apremilast) [package insert]. U.S. Food and Drug Administration.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/205437Orig1s007lbl.pdfRevisedJuly2019. Accessed August 21 2020."},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1589641"},{"issue":"2","key":"e_1_2_7_5_1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jaad.2019.08.019","article-title":"Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: results from a phase 2 open\u2010label study","volume":"82","author":"Paller AS","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.06.017"},{"issue":"20","key":"e_1_2_7_7_1","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1056\/NEJMc1901987","article-title":"Apremilast in treatment\u2010refractory recurrent aphthous stomatitis","volume":"381","author":"Kolios AGA","year":"2019","journal-title":"N Engl J Med"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816594"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13809"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2014.03.005"},{"issue":"2","key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000446836","article-title":"Apremilast use for moderate\u2010to\u2010severe atopic dermatitis in pediatric patients","volume":"8","author":"Saporito R","year":"2016","journal-title":"Case Rep Dermatol"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.812"},{"issue":"2","key":"e_1_2_7_13_1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1001\/archdermatol.2011.301","article-title":"Efficacy and safety of apremilast in chronic cutaneous sarcoidosis","volume":"148","author":"Baughman RP","year":"2012","journal-title":"Arch Dermatol"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463201402700302"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16183"},{"issue":"1","key":"e_1_2_7_16_1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaad.2018.06.046","article-title":"Apremilast for moderate hidradenitis suppurativa: results of a randomized controlled trial","volume":"80","author":"ARJV V","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.156315"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.07.014"},{"key":"e_1_2_7_19_1","first-page":"1224","article-title":"Apremilast for discoid lupus erythematosus: results of a phase 2, open\u2010label, single arm pilot study","volume":"11","author":"De Souza A","year":"2012","journal-title":"J Drugs Dermatol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.14261","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dth.14261","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.14261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:56:13Z","timestamp":1671818173000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.14261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,27]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1111\/dth.14261"],"URL":"https:\/\/doi.org\/10.1111\/dth.14261","archive":["Portico"],"relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,27]]},"assertion":[{"value":"2020-07-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}